Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shuo Liu, Zhen Qin, Yaqing Mao, Wenbo Zhang, Yujia Wang, Lingfei Jia & Xin Peng. (2022) Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma. OncoImmunology 11:1.
Read now
Read now
Yanping Ji & Yu Xue. (2020) Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma. OncoTargets and Therapy 13, pages 8395-8411.
Read now
Read now
Articles from other publishers (24)
Adam Barsouk, John Sukumar Aluru, Prashanth Rawla, Kalyan Saginala & Alexander Barsouk. (2023) Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma. Medical Sciences 11:2, pages 42.
Crossref
Crossref
Jack T. Burcher, Lindsay K. DeLiberto, Andrea M. Allen, Kaitlyn L. Kilpatrick & Anupam Bishayee. (2023) Bioactive phytocompounds for oral cancer prevention and treatment: A comprehensive and critical evaluation. Medicinal Research Reviews.
Crossref
Crossref
Raushan Kumar Chaudhary, Prakash Patil, Uday Venkat Mateti, Dhananjay B. Alagundagi & Vijith Shetty. (2023) Theranostic Potential of EFNB2 for Cetuximab Resistance in Head and Neck Cancer. Indian Journal of Otolaryngology and Head & Neck Surgery.
Crossref
Crossref
Yi‐Mei Lee, Yu‐Hsin Chen, Da‐Liang Ou, Chia‐Lang Hsu, Jia‐Hua Liu, Jenq‐Yuh Ko, Mickey C‐T Hu & Ching‐Ting Tan. (2023)
SN
‐38, an active metabolite of irinotecan, enhances
anti‐PD‐1
treatment efficacy in head and neck squamous cell carcinoma
. The Journal of Pathology 259:4, pages 428-440.
Crossref
Crossref
Zejia Yang, Jipei Liao, Lisa Schumaker, Brandon Carter-Cooper, Rena G. Lapidus, Xiaoxuan Fan, Daria A. Gaykalova, Ranee Mehra, Kevin J. Cullen & Hancai Dan. (2022) Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma. Oral Oncology 131, pages 105939.
Crossref
Crossref
Bin Qiao, Shuaize Li, Die Wang & Di Wu. (2022) Editorial: Genetics and Molecular Mechanisms of Oral and Esophageal Squamous Cell Carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Zejia Yang, Jipei Liao, Rena G. Lapidus, Xiaoxuan Fan, Ranee Mehra, Kevin J. Cullen & Hancai Dan. (2022) Targeting Wee1 kinase to suppress proliferation and survival of cisplatin-resistant head and neck squamous cell carcinoma. Cancer Chemotherapy and Pharmacology 89:4, pages 469-478.
Crossref
Crossref
Robert Kleszcz & Jarosław Paluszczak. (2021) The combinatorial inhibition of Wnt signaling and Akt kinase is beneficial for reducing the survival and glycolytic activity of tongue cancer cells. Journal of Oral Pathology & Medicine 51:3, pages 231-239.
Crossref
Crossref
Shyla Gopalakrishnan, Soumya Krishnan Uma, Gayathri Mohan, Amrutha Mohan, Geetha Shanmugam, Vineeth T. V. Kumar, Sreekumar J, Sivakumar K. Chandrika, Dileep Vasudevan, Sai Ravi Chandra Nori, Shijulal Nelson Sathi, Sanil George & Tessy Thomas Maliekal. (2021) SSTP1, a Host Defense Peptide, Exploits the Immunomodulatory IL6 Pathway to Induce Apoptosis in Cancer Cells. Frontiers in Immunology 12.
Crossref
Crossref
Ji Ma, Shudong Ma, Ying Zhang, Yi Shen, Lei Huang, Tianhao Lu, Lu Wang, Yunhan Wen & Zhenhua Ding. (2021) Kinectin1 depletion promotes EGFR degradation via the ubiquitin-proteosome system in cutaneous squamous cell carcinoma. Cell Death & Disease 12:11.
Crossref
Crossref
Lihua Zuo, Zhuo Chen, Lihuang Chen, Jian Kang, Yingying Shi, Liwei Liu, Shuhua Zhang, Qingquan Jia, Yi Huang & Zhi Sun. (2021) Integrative Analysis of Metabolomics and Transcriptomics Data Identifies Prognostic Biomarkers Associated With Oral Squamous Cell Carcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Junko TakeiTeizo AsanoHiroyuki SuzukiMika K. KanekoYukinari Kato. (2021)
Epitope Mapping of the Anti-CD44 Monoclonal Antibody (C
44
Mab-46) Using Alanine-Scanning Mutagenesis and Surface Plasmon Resonance
. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 40:5, pages 219-226.
Crossref
Crossref
Ji Hyun Lee, Seong Gu Heo, Beung‐Chul Ahn, Min Hee Hong, Byoung Chul Cho, Sun Min Lim & Hye Ryun Kim. (2021) A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Cancer Medicine 10:20, pages 7012-7020.
Crossref
Crossref
Lingfei Jia, Yilun Wang & Cun‐Yu Wang. (2021) circFAT1 Promotes Cancer Stemness and Immune Evasion by Promoting STAT3 Activation. Advanced Science 8:13, pages 2003376.
Crossref
Crossref
Maria L. Espinosa, Chelsea Abad, Yaira Kurtzman & Farah R. Abdulla. (2021) Dermatologic Toxicities of Targeted Therapy and Immunotherapy in Head and Neck Cancers. Frontiers in Oncology 11.
Crossref
Crossref
Yimin Xu, Gangcai Zhu, Christopher A. Maroun, Irene X. Y. Wu, Donghai Huang, Tanguy Y. Seiwert, Yong Liu, Rajarsi Mandal & Xin Zhang. (2021) Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis. Frontiers in Immunology 12.
Crossref
Crossref
Garrett L. Jensen, Gabriel Axelrud, David Fink, Kendall Hammonds, Kimberly Walker, Marcus Volz, Alan Gowan, Arundhati Rao, Niloyjyoti Deb & Sameer G. Jhavar. (2021) Improved local control in p16 negative oropharyngeal cancers with hypermethylated MGMT. Radiotherapy and Oncology 157, pages 234-240.
Crossref
Crossref
Rolando Pérez-Lorenzo, Stephanie O. Erjavec, Angela M. Christiano & Raphael Clynes. (2021) Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted therapy in mouse models of melanoma. Oncotarget 12:2, pages 66-80.
Crossref
Crossref
Ines De Pauw, Carolien Boeckx & An Wouters. 2021. Critical Issues in Head and Neck Oncology. Critical Issues in Head and Neck Oncology
21
51
.
Jeremy J.P. Shaw, Timothy L. Boyer, Emily Venner, Patrick J. Beck, Tristen Slamowitz, Tara Caste, Alexandra Hickman, Michael H. Raymond, Pedro Costa-Pinheiro, Mark J. Jameson, Todd E. Fox & Mark Kester. (2020) Inhibition of Lysosomal Function Mitigates Protective Mitophagy and Augments Ceramide Nanoliposome–Induced Cell Death in Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics 19:12, pages 2621-2633.
Crossref
Crossref
Lingfei Jia, Wuchang Zhang & Cun-Yu Wang. (2020) BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse. Cell Stem Cell 27:2, pages 238-253.e6.
Crossref
Crossref
Martijn van der Heijden, Paul B. M. Essers, Monique C. de Jong, Reinout H. de Roest, Sebastian Sanduleanu, Caroline V. M. Verhagen, Olga Hamming-Vrieze, Frank Hoebers, Philippe Lambin, Harry Bartelink, C. René Leemans, Marcel Verheij, Ruud H. Brakenhoff, Michiel W. M. van den Brekel & Conchita Vens. (2020) Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation. Frontiers in Oncology 9.
Crossref
Crossref
Yoon Se Lee. (2019) Current Development and Research Trend of Chemotherapeutic Agents for Head and Neck Squamous Cell Carcinoma. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 62:9, pages 487-498.
Crossref
Crossref
Bowen Yang, Jiming Shen, Lu Xu, Ying Chen, Xiaofang Che, Xiujuan Qu, Yunpeng Liu, Yuee Teng & Zhi Li. (2019) Genome-Wide Identification of a Novel Eight-lncRNA Signature to Improve Prognostic Prediction in Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology 9.
Crossref
Crossref